Back to search
Hypoxic-Ischemic Encephalopathy Mild
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypoxic-Ischemic Encephalopathy Mild trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypoxic-Ischemic Encephalopathy Mild trials you may qualify forTo determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of Therapeutic Hypotherm…
Newborns with mild hypoxic-ischemic encephalopathy usually do not receive cooling treatment. However, some of these newborns may develop neurological problems l…
Neonatal asphyxia remains a leading cause of neurodevelopmental disabilities despite advancements in perinatal care. Hypoxic-ischemic encephalopathy (HIE), a se…
A multicenter observational pilot study will be conducted to determine the natural history of infants with early diagnosis (≤ 6 hrs of age) of mild neonatal enc…
This is a Phase II multicenter placebo-controlled randomized, feasibility/safety trial. Infants \>34 week gestational age with perinatal acidemia and mild neona…
The TIME study is a randomized, controlled trial to evaluate impact on early measures of neurodevelopment and the safety profile of therapeutic hypothermia in t…